Max Berry has analyzed Minicircle’s follistatin gene therapy, and I agree with his conclusion that it is unlikely to be effective. There are several aspects of their design that could be improved (in particular, using a more efficient lipid nanoparticle delivery system instead of PEI, and making a better choice of promoter). Overall, it seems like they are overcharging for a product of limited value.
I’m posting this here because there has recently been substantial discussion of Minicircle in the rationalist community.
On Minicircle
Link post
Max Berry has analyzed Minicircle’s follistatin gene therapy, and I agree with his conclusion that it is unlikely to be effective. There are several aspects of their design that could be improved (in particular, using a more efficient lipid nanoparticle delivery system instead of PEI, and making a better choice of promoter). Overall, it seems like they are overcharging for a product of limited value.
I’m posting this here because there has recently been substantial discussion of Minicircle in the rationalist community.